Triple fixed-dose combination of amlodipine, indapamide and perindopril for hypertension in patients with stable coronary artery disease and abdominal obesity
Aim. In an open-label clinical trial, to evaluate the effectiveness and impact on metabolic parameters of triple antihypertensive combination therapy with amlodipine, indapamide and perindopril arginine (perindopril A) in patients with hypertension (HTN) and stable coronary artery disease (CAD) in c...
Saved in:
Main Authors: | E. A. Polyakova, Yu. Sh. Khalimov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«FIRMA «SILICEA» LLC
2024-02-01
|
Series: | Российский кардиологический журнал |
Subjects: | |
Online Access: | https://russjcardiol.elpub.ru/jour/article/view/5753 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Triple fixed-dose combination in the treatment of hypertension: the results of the Russian observational study TRICOLOR
by: Yu. A. Karpov, et al.
Published: (2020-11-01) -
New data from a subanalysis of the TRICOLOR study: antihypertensive effectiveness of the triple single-pill combination of amlodipine/indapamide/perindopril and predictors of effectiveness and blood pressure control in young patients
by: Yu. A. Karpov, et al.
Published: (2023-11-01) -
Fixed-dose combination of amlodipine/indapamide/perindopril arginine — a rational and safe choice for blood pressure control in actual clinical setting: data of an observational program DOKAZATEL`STVO
by: J. D. Kobalava, et al.
Published: (2020-07-01) -
Effectiveness of triple fixed-dose combination in patients with inadequate blood pressure control
by: E. V. Zbyshevskaya, et al.
Published: (2022-02-01) -
Clinical effectiveness of amlodipine/indapamide/perindopril fixed-dose combination in patients with metabolic disorders: results of post hoc analyzes of the TRICOLOR study
by: Yu. A. Karpov, et al.
Published: (2024-08-01)